(May 28, 2019, 1:36 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on May 28 denied review of a circuit court of appeals ruling vacating a $3 million Paxil suicide verdict on the grounds of federal preemption (Wendy B. Dolin, et al. v. GlaxoSmithKline, LLC, et al., No. 18-803, U.S. Sup.)....